| 产品详情 |
| Edit |   |
| Product Name | SB 202190 |
| Description | MW: 331.34. |
| Size | 25 mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | n/a |
| Gene, Accession, CAS # | [SB 202190] |
| Catalog # | MBS8506322 |
| Price | |
| Order / More Info | SB 202190 from MYBIOSOURCE INC. |
| Product Specific References | Activation of the ras genes in malignant and premalignant colorectal tumors. Glarakis IS, et al. Oncol Rep. 1998 Nov-Dec;5(6):1451-4. Transformation of mammalian cells by constitutively active MAP kinase kinase Mansour SJ,et al. Science 1994;265(5174):966-970 p38 MAP kinase inhibition promotes primary tumour growth via VEGF independent mechanism. O'Sullivan AW,et al. World J Surg Oncol. 2009 Nov 15;7:89. The pharmacological and toxicological properties of this product have not been fully investi |
| 产品资料 |
|
|